Subscribe
Call Us: 02380 97 07 33

Archive for the Alerts Category

Nicorandil (Ikorel): now second-line treatment for angina – risk of ulcer complications

Nicorandil (Ikorel): now second-line treatment for angina – risk of ulcer complications

Updated advice on use of nicorandil as second-line treatment for stable angina – some ulcers may progress to complications unless treatment is stopped. More information here

Read more

Drug Alert: Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection – NOT FOR neonates and infants below one year old

Drug Alert: Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection – NOT FOR neonates and infants below one year old

by Kazeem Olalekan MRPharmS The Medicines and Healthcare products Regulatory Agency has just issued a Class 4 Drug Safety Alert for Wockhardt UK Ltd – Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection. Alert details Drug alert number EL (14)A/09 in connection with the […]

Read more

A practical point – Picato: ingenol mebutate

A practical point – Picato: ingenol mebutate

by Kazeem Olalekan MRPharmS Pharmacognosy is the branch of knowledge concerned with medicinal drugs obtained from plants or other natural sources. This has been critical to drug development and exemplified by the recent ward of the Nobel prize for medicines to the Chinese scientist Youyou Tu (a […]

Read more

Cummulative Update

Cummulative Update

by Kazeem Olalekan Over the last month, a number of important alerts have been posted on the MHRA website which we, at bookapharmacist.com, will like to draw attention (NOTE: We continue to Tweet MHRA alerts on our Twitter page – @bookapharmacist under the hashtag #mhra – so be […]

Read more

Did you miss any of these?

Did you miss any of these?

by Kazeem Olalekan MRPharmS In August a number of communications on medicines safety were sent out to healthcare professionals via the MHRA. If you missed any of it then here are the summary. Full details are available on the MHRA website. Number 1: Number 2: Number 3: […]

Read more

Febuxostat (Adenuric) and hypersensitivity reaction

Febuxostat (Adenuric) and hypersensitivity reaction

by Kazeem Olalekan Attention has just been drawn to the Drug Safety Update on Febuxostat (Adenuric) via the PJOnline website. In summary, there have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock, with febuxostat (Adenuric). Febuxostat must be stopped immediately […]

Read more

Urgent: (Action Required within 5 days) – MHRA Class 3 Alert: Cyclizine Lactate Injection 50mg/ 1ml ampoules

Urgent: (Action Required within 5 days) – MHRA Class 3 Alert: Cyclizine Lactate Injection 50mg/ 1ml ampoules

by Kazeem Olalekan MRPharmS Cyclizine Lactate Injection 50mg/ 1ml ampoules PL 00156/0096 Martindale Pharmaceuticals Ltd is recalling all remaining unexpired ampoules of the above discontinued product as a precautionary measure. This is due to a GMP concern at a third-party supplier and their own site. It is likely […]

Read more

Cloudy but clearly OK – MHRA Class 4 alert for Priadel Liquid

Cloudy but clearly OK – MHRA Class 4 alert for Priadel Liquid

A class 4 alert has been issued for Priadel Liquid by the MHRA. Priadel Liquid (Lithium Citrate 520mg/5ml equivalent to Lithium Carbonate 204mg/5ml) appears cloudy rather than clear. A detailed investigation carried out by Sanofi, the manufacturer, “has shown that the cloudiness is not due to microbial […]

Read more

Take note: PPIs and emerging issues

Take note: PPIs and emerging issues

by Kazeem Olalekan MRPharmS In August 2009 we reported a potential interaction between Proton pump inhibitors (PPI) and Clopidogrel. Subsequent to that report, Lancet concluded that PPI does not interfere with the clinical benefits of clopidogrel. The case frustrated me because in one week I was asking […]

Read more

Class 1 Drug Alert Co-codamol by Wockhardt UK Ltd Batch: LL11701

Class 1 Drug Alert Co-codamol by Wockhardt UK Ltd Batch: LL11701

A class 1 drug alert (FOR IMMEDIATE ACTION) was posted on the MHRA website last week for Co-codamol 8/500 (codeine phosphate 8mg, paracetamol 500mg) containing rogue Co-codamol 30/500 tablets! The brand affected was manufactured by Wockhardt UK Ltd. Batch No: LL11701.   Excerpts from the MHRA website […]

Read more

Safety Update: TEVA levothyroxine 100 microgram tablets

Safety Update: TEVA levothyroxine 100 microgram tablets

by Kazeem Olalekan A safety alert has come to our attention via the MHRA: Following a review by the Commission on Human Medicines (CHM), the marketing authorisation (licence) for levothyroxine 100 microgram tablets manufactured by Teva has been suspended. Teva levothyroxine 100 microgram tablets will cease to […]

Read more

Product Recall–Sterimar (Batches: FE1248b; FE1249)

Product Recall–Sterimar (Batches: FE1248b; FE1249)

The Medicines and Healthcare products Regulatory Agency (MHRA) has received warning of possible bacterial contamination in batches of the saline nasal spray Sterimar Isotonic 100ml. The spray is sold online and at high street retailers and is commonly used to cleanse the nasal passage. As part of […]

Read more

Drug Safety Alert – Dronedarone

Drug Safety Alert – Dronedarone

Dronedarone (Multaq▼) is an antiarrhythmic agent indicated in adult, clinically stable patients with history of, or current, non-permanent atrial fibrillation (AF) to prevent recurrence of AF or to lower ventricular rate. Dronedarone is available as a 400 mg film-coated tablet and the recommended dose is 400 mg […]

Read more

Class 3 Drug Alert: Novgos 3.6 mg Implant

Class 3 Drug Alert: Novgos 3.6 mg Implant

Action within 5 days Genus Pharmaceuticals Ltd is temporarily ceasing manufacture of the above product and recalling all remaining stock from pharmacy and wholesaler level. This is due to a small number of problems during implantation and the product is being withdrawn until the implantation system can […]

Read more

Class 2: Drug Alert – Gaviscon Advance

Class 2: Drug Alert – Gaviscon Advance

Gaviscon Advance Peppermint Flavour Oral suspension containing sodium alginate 500mg and potassium bicarbonate 100mg in 5ml PL 0063/0103 Batch Number Expiry Date Pack Size First Distributed 924471 1/08/2011 500 ml bottle 19/09/2009 925071 1/09/2011 500 ml bottle 19/09/2009 Reckitt Benckiser Healthcare (UK) Ltd are recalling the above […]

Read more
Page 1 of 212

Disclaimer

The information on this site is provided 'as is' Whilst we stake our reputation on producing the most accurate information (and employ reasonable care and skill in providing this site's content), we cannot warrant that the information is accurate, complete and up to date. Neither can we guarantee uninterrupted performance and durability.
Click here to read our complete terms and conditions.